[1] de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol,2015,63: 743-752.
[2] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol,2016,64: 179-202.
[3] MartínLlahí M, Albillos A, Baares, et al. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver. Gastroenterol Hepatol,2017,40: 538-580.
[4] Khanna R, Sarin SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction. Hepatol Int,2018,12: 148-167.
[5] Khanna R, Sarin SK. Non-cirrhotic portal hypertension-diagnosis and management. J Hepatol,2014,60: 421-441.
[6] Lee H, Rehman AU, Fiel MI. Idiopathic Noncirrhotic Portal Hypertension: An Appraisal. J Pathol Transl Med,2016,50: 17-25.
[7] Siramolpiwat S, Seijo S, Miquel R, et al. Idiopathic portal hypertension: natural history and long-term outcome. Hepatology,2014,59: 2276-2285.
[8] Zuo C, Chumbalkar V, Ells PF, et al. Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies. Hepatol Int,2017,11: 452-460.
[9] Guido M, Sarcognato S, Sacchi D, et al. Pathology of idiopathic non-cirrhotic portal hypertension. Virchows Arch,2018,473: 23-31.
[10] Guido M, Alves V AF, Balabaud C, et al. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition. Histopathology 2019,74:219-226.
[11] Rajesh S, Mukund A, Sureka B, et al. Non-cirrhotic portal hypertension: an imaging review. Abdom Radiol (NY),2018,43: 1991-2010.
[12] Maruyama H, Shimada T, Ishibashi H, et al. Delayed periportal enhancement: a characteristic finding on contrast ultrasound in idiopathic portal hypertension. Hepatol Int,2012,6: 511-519.
[13] Seijo S, Lozano JJ, Alonso C, et al. Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension. Am J Gastroenterol, 2013,108: 926-932.
[14] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology,2017, 65: 310-335.
[15] Regnault D, D′alteroche L, Nicolas C, et al. Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol,2018,30: 557-562. |
